Listed

Jade Biosciences, Inc.

JBIONasdaqCIK 1798749HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$58.9m, Q2 FY2026
Net income−$55.8m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m16.9Research and development, Q3 FY2023, three months to 2023-09-30$16.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figure17.8Research and development, Q4 FY2023, three months to 2023-12-31$17.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0001558370-25-003750. Derived: 12-month figure less the 9-month figure.Report this figure20.1Research and development, Q1 FY2024, three months to 2024-03-31$20.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure21.2Research and development, Q2 FY2024, three months to 2024-06-30$21.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-08-12, accession 0001798749-24-000049.Report this figure13.6Research and development, Q3 FY2024, three months to 2024-09-30$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure1.5Research and development, Q4 FY2024, three months to 2024-12-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0001558370-25-003750. Derived: 12-month figure less the 9-month figure.Report this figure20.0Research and development, Q1 FY2025, three months to 2025-03-31$20.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure22.5Research and development, Q2 FY2025, three months to 2025-06-30$22.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure22.0Research and development, Q3 FY2025, three months to 2025-09-30$22.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure28.5Research and development, Q4 FY2025, three months to 2025-12-31$28.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-06, accession 0001193125-26-096550. Derived: 12-month figure less the 9-month figure.Report this figure36.1Research and development, Q1 FY2026, three months to 2026-03-31$36.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure50.1Research and development, Q2 FY2026, three months to 2026-06-30$50.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure
Operating income$m(21.4)Operating income, Q3 FY2023, three months to 2023-09-30−$21.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figure(22.1)Operating income, Q4 FY2023, three months to 2023-12-31−$22.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0001558370-25-003750. Derived: 12-month figure less the 9-month figure.Report this figure(24.6)Operating income, Q1 FY2024, three months to 2024-03-31−$24.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure(26.2)Operating income, Q2 FY2024, three months to 2024-06-30−$26.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-08-12, accession 0001798749-24-000049.Report this figure(15.0)Operating income, Q3 FY2024, three months to 2024-09-30−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure(6.4)Operating income, Q4 FY2024, three months to 2024-12-31−$6.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0001558370-25-003750. Derived: 12-month figure less the 9-month figure.Report this figure(23.4)Operating income, Q1 FY2025, three months to 2025-03-31−$23.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure(27.8)Operating income, Q2 FY2025, three months to 2025-06-30−$27.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure(27.4)Operating income, Q3 FY2025, three months to 2025-09-30−$27.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure(35.0)Operating income, Q4 FY2025, three months to 2025-12-31−$35.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-06, accession 0001193125-26-096550. Derived: 12-month figure less the 9-month figure.Report this figure(43.4)Operating income, Q1 FY2026, three months to 2026-03-31−$43.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure(58.9)Operating income, Q2 FY2026, three months to 2026-06-30−$58.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$mnot reportednot reportednot reportednot reported0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figurenot reportednot reported0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure0.1Income tax, Q4 FY2025, three months to 2025-12-31$58.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-06, accession 0001193125-26-096550. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$16.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$15.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure
Net income$m(19.6)Net income, Q3 FY2023, three months to 2023-09-30−$19.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figure(20.4)Net income, Q4 FY2023, three months to 2023-12-31−$20.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0001558370-25-003750. Derived: 12-month figure less the 9-month figure.Report this figure(23.2)Net income, Q1 FY2024, three months to 2024-03-31−$23.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure(24.8)Net income, Q2 FY2024, three months to 2024-06-30−$24.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figure(16.3)Net income, Q3 FY2024, three months to 2024-09-30−$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure(5.4)Net income, Q4 FY2024, three months to 2024-12-31−$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0001558370-25-003750. Derived: 12-month figure less the 9-month figure.Report this figure(38.2)Net income, Q1 FY2025, three months to 2025-03-31−$38.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure(32.1)Net income, Q2 FY2025, three months to 2025-06-30−$32.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure(25.2)Net income, Q3 FY2025, three months to 2025-09-30−$25.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure(31.9)Net income, Q4 FY2025, three months to 2025-12-31−$31.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-06, accession 0001193125-26-096550. Derived: 12-month figure less the 9-month figure.Report this figure(40.4)Net income, Q1 FY2026, three months to 2026-03-31−$40.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure(55.8)Net income, Q2 FY2026, three months to 2026-06-30−$55.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure
Diluted EPS$ per share(0.71)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figurenot reported(0.83)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure(0.86)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-08-12, accession 0001798749-24-000049.Report this figure(5.16)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$5.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figurenot reported(12.10)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$12.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure(0.86)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure(0.48)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figurenot reported(0.57)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure(0.76)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure
Basic EPS$ per share(0.71)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figurenot reported(0.83)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.83 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure(0.86)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.86 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-08-12, accession 0001798749-24-000049.Report this figure(5.16)Basic EPS, Q3 FY2024, three months to 2024-09-30−$5.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figurenot reported(12.10)Basic EPS, Q1 FY2025, three months to 2025-03-31−$12.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure(0.86)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.86 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure(0.48)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figurenot reported(0.57)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure(0.76)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure

Balance sheet

Cash and equivalents$107.3m, Q2 FY2026
Shareholders' equity$439.9m, Q2 FY2026
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31period not labelled2024-06-17Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m23.5Cash and equivalents, FY2023, at 2023-12-31$23.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0001558370-25-003750.Report this figure9.1Cash and equivalents, Q1 FY2024, at 2024-03-31$9.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0001558370-24-007985.Report this figurenot reported31.1Cash and equivalents, Q2 FY2024, at 2024-06-30$31.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-12, accession 0001798749-24-000049.Report this figure31.1Cash and equivalents, Q3 FY2024, at 2024-09-30$31.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figure69.4Cash and equivalents, FY2024, at 2024-12-31$69.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-06, accession 0001193125-26-096550.Report this figure44.2Cash and equivalents, Q1 FY2025, at 2025-03-31$44.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure221Cash and equivalents, Q2 FY2025, at 2025-06-30$220.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001193125-25-179853.Report this figure50.1Cash and equivalents, Q3 FY2025, at 2025-09-30$50.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure88.4Cash and equivalents, FY2025, at 2025-12-31$88.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure55.1Cash and equivalents, Q1 FY2026, at 2026-03-31$55.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure107Cash and equivalents, Q2 FY2026, at 2026-06-30$107.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure
Current assets$m124Current assets, FY2023, at 2023-12-31$124.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0001558370-25-003750.Report this figure103Current assets, Q1 FY2024, at 2024-03-31$103.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001558370-24-007985.Report this figurenot reported111Current assets, Q2 FY2024, at 2024-06-30$110.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0001798749-24-000049.Report this figure90.6Current assets, Q3 FY2024, at 2024-09-30$90.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figure69.7Current assets, FY2024, at 2024-12-31$69.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-06, accession 0001193125-26-096550.Report this figure77.4Current assets, Q1 FY2025, at 2025-03-31$77.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure223Current assets, Q2 FY2025, at 2025-06-30$223.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001193125-25-179853.Report this figure201Current assets, Q3 FY2025, at 2025-09-30$201.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure349Current assets, FY2025, at 2025-12-31$348.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure319Current assets, Q1 FY2026, at 2026-03-31$318.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure471Current assets, Q2 FY2026, at 2026-06-30$471.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure
Total assets$m127Total assets, FY2023, at 2023-12-31$127.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0001558370-25-003750.Report this figure107Total assets, Q1 FY2024, at 2024-03-31$106.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001558370-24-007985.Report this figurenot reported112Total assets, Q2 FY2024, at 2024-06-30$111.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0001798749-24-000049.Report this figure91.0Total assets, Q3 FY2024, at 2024-09-30$91.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figure72.8Total assets, FY2024, at 2024-12-31$72.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-06, accession 0001193125-26-096550.Report this figure77.5Total assets, Q1 FY2025, at 2025-03-31$77.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure224Total assets, Q2 FY2025, at 2025-06-30$224.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001193125-25-179853.Report this figure202Total assets, Q3 FY2025, at 2025-09-30$202.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure350Total assets, FY2025, at 2025-12-31$349.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure319Total assets, Q1 FY2026, at 2026-03-31$319.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure472Total assets, Q2 FY2026, at 2026-06-30$472.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure
Current liabilities$m17.6Current liabilities, FY2023, at 2023-12-31$17.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0001558370-25-003750.Report this figure15.5Current liabilities, Q1 FY2024, at 2024-03-31$15.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001558370-24-007985.Report this figurenot reported17.0Current liabilities, Q2 FY2024, at 2024-06-30$17.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0001798749-24-000049.Report this figure10.3Current liabilities, Q3 FY2024, at 2024-09-30$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figure12.0Current liabilities, FY2024, at 2024-12-31$12.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-06, accession 0001193125-26-096550.Report this figure2.4Current liabilities, Q1 FY2025, at 2025-03-31$2.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure21.6Current liabilities, Q2 FY2025, at 2025-06-30$21.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001193125-25-179853.Report this figure22.4Current liabilities, Q3 FY2025, at 2025-09-30$22.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure16.5Current liabilities, FY2025, at 2025-12-31$16.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure22.3Current liabilities, Q1 FY2026, at 2026-03-31$22.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure31.6Current liabilities, Q2 FY2026, at 2026-06-30$31.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure
Total liabilities$m18.0Total liabilities, FY2023, at 2023-12-31$18.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0001558370-25-003750.Report this figure15.9Total liabilities, Q1 FY2024, at 2024-03-31$15.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001558370-24-007985.Report this figurenot reported17.3Total liabilities, Q2 FY2024, at 2024-06-30$17.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0001798749-24-000049.Report this figure10.5Total liabilities, Q3 FY2024, at 2024-09-30$10.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figure120Total liabilities, FY2024, at 2024-12-31$119.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-06, accession 0001193125-26-096550.Report this figure2.5Total liabilities, Q1 FY2025, at 2025-03-31$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure22.4Total liabilities, Q2 FY2025, at 2025-06-30$22.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001193125-25-179853.Report this figure23.1Total liabilities, Q3 FY2025, at 2025-09-30$23.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure17.3Total liabilities, FY2025, at 2025-12-31$17.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure23.0Total liabilities, Q1 FY2026, at 2026-03-31$23.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure32.2Total liabilities, Q2 FY2026, at 2026-06-30$32.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure
Shareholders' equity$m109Shareholders' equity, FY2023, at 2023-12-31$109.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure90.9Shareholders' equity, Q1 FY2024, at 2024-03-31$90.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure0.0Shareholders' equity, period not labelled, at 2024-06-17$1.0k. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-06, accession 0001193125-26-096550.Report this figure(0.6)Shareholders' equity, Q2 FY2024, at 2024-06-30−$589.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure(16.9)Shareholders' equity, Q3 FY2024, at 2024-09-30−$16.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure(46.8)Shareholders' equity, FY2024, at 2024-12-31−$46.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure(83.5)Shareholders' equity, Q1 FY2025, at 2025-03-31−$83.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure202Shareholders' equity, Q2 FY2025, at 2025-06-30$201.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure179Shareholders' equity, Q3 FY2025, at 2025-09-30$179.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure333Shareholders' equity, FY2025, at 2025-12-31$332.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure296Shareholders' equity, Q1 FY2026, at 2026-03-31$296.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure440Shareholders' equity, Q2 FY2026, at 2026-06-30$439.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure

Cash flow

Operating cash flow−$43.7m, Q2 FY2026
Capital expenditure$3.0k, Q4 FY2025
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(15.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$15.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001798749-24-000059. Derived: 9-month figure less the 6-month figure.Report this figure(14.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0001558370-25-003750. Derived: 12-month figure less the 9-month figure.Report this figure(23.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$23.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure(20.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$20.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-08-12, accession 0001798749-24-000049. Derived: 6-month figure less the 3-month figure.Report this figure(6.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure(11.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$11.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0001558370-25-003750. Derived: 12-month figure less the 9-month figure.Report this figure(18.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$18.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure(20.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$20.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-341242. Derived: 6-month figure less the 3-month figure.Report this figure(22.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$22.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-281525. Derived: 9-month figure less the 6-month figure.Report this figure(33.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$33.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-06, accession 0001193125-26-096550. Derived: 12-month figure less the 9-month figure.Report this figure(24.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$24.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure(43.7)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$43.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-341242. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$32.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001798749-24-000059. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$64.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0001558370-25-003750. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$57.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001193125-25-281525. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-06, accession 0001193125-26-096550. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)61.05m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares24.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3024,454,786 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001798749-23-000060.Report this figure24.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3124,777,847 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0001558370-24-007985.Report this figure25.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3025,166,505 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0001798749-24-000049.Report this figure27.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3027,640,542 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001798749-24-000059.Report this figure27.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3127,795,827 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-25, accession 0001558370-25-005564.Report this figure28.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3028,756,043 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0001798749-24-000049.Report this figure3.2Diluted shares (weighted), Q3 FY2024, three months to 2024-09-303,155,500 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure3.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-313,155,500 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure28.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3028,431,158 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure39.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3039,584,489 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001193125-25-281525.Report this figure57.8Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3157,777,165 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212088.Report this figure61.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3061,050,775 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure

Shares outstanding: 63.60mShares outstanding, period not labelled, at 2026-08-0363,597,387 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-341242.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.